Results 41 to 50 of about 189,087 (191)

The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited [PDF]

, 2017
BACKGROUND: To compare a near decade of follow-up, newer control cohort data, use of both the societal and third party insurer cost perspectives, and integration of unilateral/bilateral therapy on the comparative effectiveness and cost-effectiveness of ...
Adam Turpcu, Gary C. Brown, Heidi B. Lieske, Melissa M. Brown, Yamina Rajput   +4 more
core   +1 more source

Comparison of the 2-Year Results of Photodynamic Therapy with Aflibercept and Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Clinical Ophthalmology, 2023
Tomoko Miyakubo, Ryo Mukai, Hidetaka Matsumoto, Masahiro Morimoto, Maki Takahashi, Kazuki Nagai, Kosuke Nakamura, Junki Hoshino, Hideo Akiyama Department of Ophthalmology, Gunma University, Graduate School of Medicine, Maebashi, Gunma ...
Miyakubo T, Mukai R, Matsumoto H, Morimoto M, Takahashi M, Nagai K, Nakamura K, Hoshino J, Akiyama H   +8 more
doaj  

Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion

Ophthalmology and Therapy, 2019
Introduction To report the 52-week treatment outcomes with intravitreal injections of aflibercept using a treat-and-extend regimen for treating macular edema secondary to central retinal vein occlusion (CRVO). Methods A retrospective analysis of patients
Maria Eleftheriadou, Luke Nicholson, Giulia D’Alonzo, Peter K. F. Addison   +3 more
doaj   +1 more source

Long-term results of anti-VEGF therapy in macular edema caused by central retinal vein occlusion

Российский офтальмологический журнал, 2023
Purpose. To evaluate long-term results of anti-VEGF therapy performed in a modified “treat-and-extend” regimen in macular edema secondary to central retinal vein occlusion.Material and methods.
A. B. Galimova, V. U. Galimova
doaj   +1 more source

Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study [PDF]

, 2017
PURPOSE: The purpose of this study is to compare the efficacy and safety of intravitreal aflibercept (IVA) with sham photodynamic therapy (sPDT) versus IVA with verteporfin PDT (vPDT) in a Caucasian population with treatment-naive polypoidal choroidal ...
Costa, MÂ, Farinha, C, Ferrão, Â, Marques, JP, Nunes, S, Silva, R   +5 more
core   +1 more source

Treatment of exudative age-related macular degeneration with intravitreal ranibizumab in clinical practice: a 3-year follow-up [PDF]

, 2013
PURPOSE: To evaluate the 36-month efficacy of intravitreal ranibizumab injections for choroidal neovascularization secondary to age-related macular degeneration (AMD) in real world clinical practice.
Faria de Abreu, JR, Figueira, J, Fonseca, P, Luz Cachulo, M, Marques, I, Pires, I, Silva, R   +6 more
core   +1 more source

Association Between Visual Acuity and Fluid Compartments with Treat-and-Extend Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: An ARIES Post Hoc Analysis. [PDF]

, 2022
INTRODUCTION Recently, there has been growing interest in exploring the relationship between visual acuity and fluid localization in different retinal compartments.
Allmeier, Helmut, Chaudhary, Varun, Holz, Frank G, Lambrou, George, Machewitz, Tobias, Midena, Edoardo, Mitchell, Paul, Souied, Eric H, Wolf, Sebastian   +8 more
core   +1 more source

Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol. [PDF]

, 2020
AimTo show the characteristics and outcomes of patients with neovascular age-related macular degeneration (nAMD) who had extended remission (ER) while on a pro re nata (PRN) treatment protocol.MethodsThis was a retrospective case-control study of a ...
Amador-Patarroyo, Manuel J, Cheng, Lingyun, Dans, Kunny C, Freeman, William R, Lin, Tiezhu, Meshi, Amit, Muftuoglu, Ilkay Kilic   +6 more
core  

Reducing the clinical burden of ranibizumab treatment for neovascular age-related macular degeneration using an individually planned regimen. [PDF]

, 2014
AIMS: The purpose of this study was to clinically validate an individually planned treatment regimen for neovascular age-related macular degeneration (nAMD), termed, observe and plan.
Ambresin, A., Deli, A., Gianniou, C., Mantel, I., Niderprim, S.A.   +4 more
core   +1 more source

Age, Initial Central Retinal Thickness, and OCT Biomarkers Have an Influence on the Outcome of Diabetic Macular Edema Treated With Ranibizumab– Tri-center 12-Month Treat-and-Extend Study

Frontiers in Medicine, 2021
Objective: We report the tri-center 1-year outcomes of a treat-and-extend (T&E) regimen in four-week intervals with ranibizumab for diabetic macular edema (DME).Methods: In this retrospective study, all eyes received 3 monthly loading injections of 0.
Chun-Ting Lai, Yi-Ting Hsieh, Chun-Ju Lin, Chun-Ju Lin, Chun-Ju Lin, Jia-Kang Wang, Jia-Kang Wang, Chih-Ying Lin, Chih-Ying Lin, Ning-Yi Hsia, Ning-Yi Hsia, Henry Bair, Huan-Sheng Chen, Chiung-Yi Chiu, Shao-Wei Weng   +14 more
doaj   +1 more source